Home > Boards > US Listed > Biotechs > Opko Health Inc (OPK)

Brand new Dr. Frost investment this morning 8K

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
rtraster Member Profile
 
Followed By 6
Posts 245
Boards Moderated 0
Alias Born 09/05/13
160x600 placeholder
OPKO Health Q2 growth slows amid waning pandemic impact Seeking Alpha - 7/29/2021 5:15:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 7/29/2021 4:24:27 PM
OPKO Health EPS misses by $0.05, misses on revenue Seeking Alpha - 7/29/2021 4:12:13 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/29/2021 4:08:36 PM
OPKO Health Reports 2021 Second Quarter Business Highlights and Financial Results GlobeNewswire Inc. - 7/29/2021 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/12/2021 1:51:49 PM
OPKO Health licenses oligonucleotide therapeutics platform to CAMP4 Therapeutics Seeking Alpha - 7/12/2021 8:51:33 AM
OPKO Health Licenses Oligonucleotide Therapeutics Platform to CAMP4 Therapeutics GlobeNewswire Inc. - 7/12/2021 8:00:00 AM
OPKO Health to Present at the Ladenburg Thalmann Healthcare Conference GlobeNewswire Inc. - 7/8/2021 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/25/2021 4:26:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2021 8:48:11 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2021 8:47:31 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2021 8:47:26 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2021 8:44:34 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2021 8:42:11 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/23/2021 4:50:26 PM
OPKO Health Appoints Katherine Stueland as President and CEO of GeneDx GlobeNewswire Inc. - 6/22/2021 8:00:00 AM
BioReference Laboratories Announces First COVID-19 Testing Program for Cruise Industry PR Newswire (US) - 6/22/2021 7:39:00 AM
OPKO Health to Develop and Commercialize RAYALDEE® in Greater China with Nicoya Therapeutics GlobeNewswire Inc. - 6/21/2021 8:03:07 AM
OPKO Health Announces Sale of its Sterile Fill and Finish Manufacturing Facility in Ireland GlobeNewswire Inc. - 6/17/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2021 7:28:25 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/1/2021 2:41:51 PM
Cocrystal Pharma Announces the Passing of Chairman, CEO and Co-founder Dr. Gary Wilcox GlobeNewswire Inc. - 5/28/2021 8:00:00 AM
OPKO Health to Participate in the Jefferies Virtual Healthcare Conference GlobeNewswire Inc. - 5/27/2021 8:30:00 AM
OPKO Health perks up amid insider purchase Seeking Alpha - 5/26/2021 1:38:29 PM
rtraster   Thursday, 05/07/15 07:53:47 AM
Re: None
Post # of 15087 
Brand new Dr. Frost investment this morning 8K
Check out Dr. Frost's latest investment, posted around 7:30am today.

"On May 6, 2015, OPKO Health, Inc. (“OPKO”), a multi-national biopharmaceutical and diagnostics company, agreed to participate in the Offering. Dr. Phillip Frost and Steve Rubin, who are members of the Company’s Board of Directors, are the Chief Executive Officer and Chairman and Executive Vice President-Administration of OPKO, respectively."

SEC Form 8-K here --- >
http://www.sec.gov/Archives/edgar/data/1035354/000114420415028099/v409746_8k.htm

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences